“Biosimilars LatAm has become a forum where we come every year to talk, discuss, and exchange information, ideas, opinions, and updates about the state of regulation, scientific development, new partners, and the new solutions our suppliers have to offer. I think this is an experience everyone should have, and all I can say is that next year I hope to see even more colleagues here so we can continue discussing these fascinating topics.”

Nestor Perez, Director of operations at PROBIOMED, Mexico

“The contributions have been incredibly interesting. The topic of biosimilars is multifactorial—we’ve heard from specialists in regulatory affairs, intellectual property, investments, and more, and it’s been a truly enriching experience. I invite you to attend the next time this event takes place, as it’s an excellent opportunity for all of us to connect, network, and move biosimilar projects forward.”

Gloria Berruti, Director of International Business Latam at Neolpharma, Mexico

“Very enriching event where different attendees from the regulatory, scientific, manufacturing, as well as commercial background came together to find out the solutions to create the main access for more and more biosimilars and biotechnology products in the Latin American region, especially in Mexico. So this event was very interactive. There’s a lot of very strong panel discussions as well as presentation. Also, some of the international and overseas faculties brought a lot of enriching experience. So overall, it was a great event, and I will encourage that participants should join hands together along with the regulatory authorities in such events.”

Raman Wattamwar, CEO at Innovex International, India

“This forum has been a very interesting exchange of ideas, and the upcoming ones promise to be even more engaging.”

Jaime Uribe, CEO at Probiomed, Mexico

“I’d like to invite everyone to join us next year, where we will discuss new opportunities in the market. In 2024, we aligned and shared strategic knowledge to help companies access other markets. Be with us in 2025.”

Talita Ferreira, Consultant at WHO, USA

“This forum has been different because many people are sharing real, honest, and practical opinions, which I’ve found very valuable. I invite you to next year’s forum, which will be just as valuable—if not more.”

Pedro Chavarría, Regulatory Affairs Director at Teva, Mexico

“It truly is an event that brings together experts not only from Mexico but from all over Latin America. It’s an excellent forum for exchanging ideas, staying up-to-date, and building relationships that can help drive biotechnology and biosimilars throughout the region. I’d like to invite you all to attend the next event next year, or any other events related to this topic, which is so important for the region, for Mexico, and especially for patients.”

Sonia Mayra Perez, CEO at UDIBI, Mexico

“Forum dedicated to studying and presenting very important technical and regulatory topics, not only for Mexico but also for all of Latin America. It has been a space where we’ve been able to create synergies, network, and communicate with the different players in the biosimilars industry. I invite you to join us next year at the same forum, Biosimilars LatAm – Mexico 2025”

Jose Avalos, Co Founder & General Manager at Nouvelle Pharmaceutiques, Mexico

“I’ve learned a lot here, and I’ve also had the opportunity to collaborate with different people and groups at an international level, which has allowed me to see where both vaccines and public health are heading in our region.”

Yolanda Cervantes, Medical Director at Grin, Mexico

“It’s a forum with many important people, where we can exchange valuable input and share great ideas. We look forward to seeing you next year.”

Oscar Bustamente, Regulatory Affairs Manager at Adium, Mexico

“We had a very good opportunity to speak with our customers, generate new networks and new practices, and generate new opportunities for the future. So I am very glad to stay here this year, and I hope to see you the next year.”

Vinicius Marçal, Business Development Manager Latam at Cytiva, Brazil

“It has been a great opportunity to learn about the latest developments in biosimilars in the region and all the opportunities we have to collaborate with different companies. I strongly encourage you to share your outstanding new ideas on this topic and to join us next year.”

Fernando Goicoechea, General Manager Latam at Goicoechea & Associates, USA

“It’s been a great forum, with excellent interaction and, above all, very enjoyable networking. I hope you’ll join us next year at Biosimilars Mexico 2025, come connect with others, and talk with experts in the biopharmaceutical field in Mexico and Latin America so we can share our experiences.”

Mario Novoa, Sales & Application Specialist at Infors, Mexico

“It’s a space where we can do a lot of networking and collaborate. There are many interesting topics, and I encourage you to join us next year. I’m sure this great experience will be repeated.”

Mauricio Barron, Process Application specialist at Merck, Mexico

“It’s an excellent forum to exchange ideas and meet people—especially now in these post-pandemic times, when personal connection is so important. From the 2024 event, I’m taking away new relationships, new knowledge, and I hope that next year this forum continues, grows, and keeps providing us with valuable insights for the biosimilars industry.”

Oscar Gamiz, Sr. Marketing Manager PS LATAM at BD, Mexico